- Home
- TWST vs TLRY Comparison
TWST vs TLRY Comparison
Compare TWST & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TWST | TLRY |
|---|---|---|
| Founded | 2013 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.7B |
| IPO Year | 2018 | 2018 |
Fundamental Metrics
Financial Performance| Metric | TWST | TLRY |
|---|---|---|
| Price | $35.16 | $10.67 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 3 |
| Target Price | $44.88 | ★ $150.00 |
| AVG Volume (30 Days) | 1.3M | ★ 19.1M |
| Earning Date | 02-02-2026 | 01-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $376,572,000.00 | ★ $830,766,000.00 |
| Revenue This Year | $15.19 | $7.28 |
| Revenue Next Year | $15.10 | $4.51 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 20.32 | 2.31 |
| 52 Week Low | $23.30 | $3.51 |
| 52 Week High | $55.33 | $23.20 |
Technical Indicators
Market Signals| Indicator | TWST | TLRY |
|---|---|---|
| Relative Strength Index (RSI) | 65.30 | 65.47 |
| Support Level | $30.21 | $10.50 |
| Resistance Level | $33.75 | $15.70 |
| Average True Range (ATR) | 1.89 | 1.42 |
| MACD | 0.28 | 0.25 |
| Stochastic Oscillator | 97.56 | 42.45 |
Price Performance
Historical ComparisonAbout TWST Twist Bioscience Corporation
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.
About TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mostly from alcohol.